经椎间孔椎体间融合术治疗复发性腰椎椎间盘突出症的疗效分析  

Transforaminal lumbar interbody fusion for treatment of recurrent lumbar disc herniation: an analysis of therapeutic effect

作　　者：张剑刚[1] 丁文元[1] 申勇[1] 徐佳欣[1] 安志辉[1] 杨少坤[1] 

机构地区：[1]河北医科大学第三医院脊柱外科,河北050051

出　　处：《脊柱外科杂志》2011年第4期232-235,共4页Journal of Spinal Surgery

摘　　要：目的探讨经椎间孔椎体间融合术(transforaminal lumbar interbody fusion,TLIF)治疗复发性腰椎椎间盘突出症(recurrent lumbar disc herniation,RLDH)的疗效。方法 2008年2月～2010年6月应用TLIF技术再手术治疗的RLDH患者27例,年龄为28～64岁,平均52.4岁。采用日本骨科学会(Japanese Orthopaedic Association,JOA)评分系统、Nakai标准评价治疗效果,Suk方法评价植骨融合情况。结果患者均获得随访,随访时间为8～36个月(平均23个月)。术后根据JOA评分,优20例,良7例,平均改善率88.5%;根据Nakai评分标准,优18例,良6例,可3例,优良率88.9%;根据Suk标准患者椎间植骨均获得骨性融合。结论 TLIF是治疗RLDH的有效术式,可以获得满意临床效果。Objective To assess the therapeutic effect of transforaminal lumbar interbody fusion（TLIF） in treatment of recurrent lumbar disc herniation.Methods From February 2008 to June 2010,27 patients（average age 52.4,ranging 28~64 years old） with recurrent lumbar disc herniation,who had been treated by TLIF,were collected in the present study.Japanese Orthopaedic Association（JOA）score system and Nakai standards were used to evaluate the clinical results.Suk criterion was used to evaluate bone graft fusion.Results All the patients were followed up for 8-36 months（a mean of 23 months）.According to JOA score system,excellent outcomes were obtained in 20 cases and good in 7,with the average improvement rate being 88.5%.According to Nakai standard,excellent outcomes were obtained in 18 cases,good in 6 cases,and fair in 3 cases,with the excellent and good rate being 88.9%.Bone grafts in all patients were fused according to Suk criterion.Conclusion TLIF is an effective procedure for treatment of recurrent lumbar disc herniation;it can obtain satisfactory clinical results.

关 键 词：腰椎 椎间盘移位 骨移植 脊柱融合术 

分 类 号：R681.533.1[医药卫生—骨科学]